Cue Biopharma Inc. (CUE)

AI Score

Unlock

0.86

0.02 (2.83%)

At close: Apr 24, 2025, 3:51 PM

Cue Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	22.46M	48.51M	51.61M	64.37M	74.87M	44.29M	20.8M	63.53M	14.93M
Short-Term Investments	n/a	n/a	24.67M	n/a	10M	15.12M	18.41M	50.07K	50.03K
Long-Term Investments	n/a	151K	150K	150K	150K	150K	150K	n/a	n/a
Other Long-Term Assets	2.21M	2.81M	3.24M	2.86M	2.97M	3.4M	1.82M	23.28K	117K
Receivables	945K	1.7M	57.25K	3.14M	1.42M	754.9K	n/a	n/a	n/a
Inventory	n/a	n/a	1.00	1.00	n/a	15.12M	n/a	225.5K	n/a
Other Current Assets	1.73M	1.24M	841.22K	954.79K	1.24M	860.11K	104.07K	453.49K	n/a
Total Current Assets	25.14M	51.45M	77.19M	68.47M	87.53M	61.02M	40.61M	65.07M	15.14M
Property-Plant & Equipment	4.84M	7.12M	10.7M	11.92M	8.88M	7.18M	2.78M	1.69M	1.02M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	11.67K	n/a	175K	n/a
Total Long-Term Assets	7.05M	10.08M	14.1M	14.93M	12.01M	10.58M	4.75M	1.89M	1.14M
Total Assets	32.19M	61.53M	91.28M	83.4M	99.53M	71.61M	45.36M	66.95M	16.28M
Account Payables	2.82M	3.5M	2.73M	2.59M	2.07M	882.67K	2.04M	1.33M	523.81K
Deferred Revenue	85K	2.11M	n/a	645.35K	6.68M	4.1M	2.01M	623.85K	n/a
Short-Term Debt	7.87M	3.96M	1.96M	4.93M	4.78M	4.45M	n/a	n/a	n/a
Other Current Liabilities	2.91M	1.92M	535.00	-1.67M	-2.81M	-2.87M	1.58M	2.54M	109.09K
Total Current Liabilities	13.69M	17.08M	11.55M	12.79M	16.32M	11.66M	6.22M	5.35M	1.07M
Long-Term Debt	1M	4.2M	14.05B	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-14.04B	n/a	n/a	n/a	n/a	n/a	36.36K
Total Long-Term Liabilities	1M	7.36M	14.05M	5.12M	4.31M	5.37M	5.17M	n/a	36.36K
Total Liabilities	14.69M	24.45M	25.6M	17.91M	20.62M	17.02M	11.39M	5.35M	1.1M
Total Debt	8.88M	14.7M	19.32M	10.05M	7.15M	5.8M	n/a	2.5M	n/a
Common Stock	62K	47K	43.04K	32.2K	30.35K	26.56K	20.7K	20.13K	10.64K
Retained Earnings	-341.86M	-301.19M	-250.46M	-197.45M	-153.29M	-108.5M	-71.8M	-32.82M	-9.59M
Comprehensive Income	n/a	n/a	-95.87K	-0.00	7.13K	-10.32K	-10.96K	-661.15K	-246.9K
Shareholders Equity	17.5M	37.09M	65.68M	65.49M	78.91M	54.58M	33.97M	61.61M	15.17M
Total Investments	n/a	151K	24.67M	150K	10M	15.12M	18.41M	50.07K	50.03K